High school recruiting is no longer the main focus of how to build a football roster. The transfer portal is proving that ...

AnaptysBio (NASDAQ:ANAB) outlined plans for a corporate separation and highlighted upcoming clinical and royalty-related ...

Reuters reports that Universal Music Group is set to receive conditional approval from the European Commission for its ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Ready to make your blog pay off? This guide shows you exactly how to build, grow, and monetize, with practical tips and hands ...

Royalty Pharma to provide up to $500 million, including $75 million for Phase 2b funding and a Royalty Pharma option for an additional $425 million, to support Teva's anti-IL-15 candidate, TEV-'408 TE ...

The first Sims 4 expansion of 2026 has been unveiled with a trailer and release date, and your Sims will be able to become ...

Universal Music Group is set to secure EU antitrust approval for its $775 million bid for Downtown Music after regulators ...

Under the terms of the agreement, GSK will pay RAPT Therapeutics shareholders $58.00 per share at closing for an estimated ...

Universal Music Group ‍is set to secure conditional EU antitrust ‌approval for ‌its $775 million bid for Downtown Music, ...